Richard Hoyt
Voorzitter bij ZYUS LIFE SCIENCES CORPORATION
Vermogen: 58 932 $ op 30-04-2024
Profiel
Richard Hoyt is currently the Chairman at ZYUS Life Sciences, Inc., Chairman at ZYUS Life Sciences Corp., Managing Partner at Ozark Transaction Advisors LLC, and Vice President-Business Development at Xeris Biopharma Holdings, Inc. He previously worked as the Director at Biotechnology Research & Development Corp., Independent Director at CanniMed Therapeutics, Inc. from 2012 to 2018, Vice President-Business Development at Xeris Pharmaceuticals, Inc., and Vice President-Business Development & Licensing at Mallinckrodt Plc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 09-06-2023 | 151 108 ( 0.21% ) | 58 932 $ | 30-04-2024 |
Actieve functies van Richard Hoyt
| Bedrijven | Functie | Begin |
|---|---|---|
| ZYUS LIFE SCIENCES CORPORATION | Voorzitter | 01-09-2020 |
| XERIS BIOPHARMA HOLDINGS, INC. | Corporate Officer/Principal | - |
ZYUS Life Sciences, Inc.
 ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Zyus Life Sciences, Inc. operates as a life sciences company. It?s focused on the global development and commercialization of phyto-therapeutics, including cannabinoid and protein-based formulations. The firm offers pharmaceutical-grade phyto-therapeutics, forging new pathways in medicine, cannabinoids and extraction technology. The company was founded by Brent Zettl on April 3, 2018 and is headquartered in Saskatoon, Canada. | Voorzitter | - |
| Ozark Transaction Advisors LLC | Corporate Officer/Principal | - |
Eerdere bekende functies van Richard Hoyt
| Bedrijven | Functie | Einde |
|---|---|---|
| CANNIMED THERAPEUTICS INC | Directeur/Bestuurslid | 15-03-2018 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Corporate Officer/Principal | - |
Biotechnology Research & Development Corp.
 Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Biotechnology Research & Development Corp. provides research on animal and plant healthcare, material sciences and biotechnology. The company is headquartered in Peoria, IL. | Directeur/Bestuurslid | - |
| MALLINCKRODT PLC | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| MALLINCKRODT PLC | Health Technology |
| XERIS BIOPHARMA HOLDINGS, INC. | Health Technology |
| ZYUS LIFE SCIENCES CORPORATION | Energy Minerals |
| Bedrijven in privébezit | 5 |
|---|---|
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
Biotechnology Research & Development Corp.
Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Biotechnology Research & Development Corp. provides research on animal and plant healthcare, material sciences and biotechnology. The company is headquartered in Peoria, IL. | Commercial Services |
CanniMed Therapeutics, Inc.
 CanniMed Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology CanniMed Therapeutics, Inc. operated as a biopharmaceutical company. It offered plant biotechnology research and product development programs. The firm focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. The company was founded on Oct 31st, 2016 and was headquartered in Saskatoon, Canada. | Health Technology |
ZYUS Life Sciences, Inc.
ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Zyus Life Sciences, Inc. operates as a life sciences company. It?s focused on the global development and commercialization of phyto-therapeutics, including cannabinoid and protein-based formulations. The firm offers pharmaceutical-grade phyto-therapeutics, forging new pathways in medicine, cannabinoids and extraction technology. The company was founded by Brent Zettl on April 3, 2018 and is headquartered in Saskatoon, Canada. | Health Technology |
| Ozark Transaction Advisors LLC |
